Reuters logo
BRIEF-Ziopharm and Intrexon announce cooperative research and development agreement with NCI utilizing sleeping beauty system to generate T Cells targeting Neoantigens
January 10, 2017 / 1:50 PM / in 9 months

BRIEF-Ziopharm and Intrexon announce cooperative research and development agreement with NCI utilizing sleeping beauty system to generate T Cells targeting Neoantigens

Jan 10 (Reuters) - Intrexon Corp

* Ziopharm and Intrexon announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T Cells targeting Neoantigens Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below